The current invention presents enoyl-ACP reductase, an enzyme of the type II fatty acid synthesis pathway as a target for treating human malarias and other infectious diseases. We also present in the current invention, 2-thioxothiazolidin-4-ones as antimicrobial and antimalarial agents. We provide 2-thioxothiazolidin-4-ones as antimicrobial and antimalarial agents either alone or in combination with other known antimicrobial and antimalarial agents with or without added adjuvants or diluents or carriers.
本发明将 II 型
脂肪酸合成途径中的一种酶--烯酰-ACP 还原酶作为治疗人类疟疾和其他传染性疾病的靶标。本发明还提出了作为抗菌剂和
抗疟药物的 2-
硫酮
噻唑烷-4-酮。我们提供 2-
硫酮
噻唑烷-4-酮作为抗菌剂和
抗疟药物,可以单独使用,也可以与其他已知的抗菌剂和
抗疟药物结合使用,可以添加佐剂或稀释剂或载体,也可以不添加佐剂或稀释剂或载体。